[Phosphate control in vitamin D pulse therapy for hemodialysis patients].

The efficacy of PTH suppression of oral 1,25 (OH) (2)D(3) pulse therapy was greater in the group with well-controlled phosphate levels (mean serum P<6.0 mg/dl) in hemodialysis patients with secondary hyperparathyroidism. The restriction of dietary phosphate can decrease the level of serum phosphate without increasing the dose of phosphate binders and continue the treatment without increasing Ca x P product. The dietary phosphate reduction is important in oral 1,25 (OH) (2)D(3) pulse therapy.